The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of
patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can …

BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Background Roflumilast reduces exacerbations in patients with severe chronic obstructive
pulmonary disease. Its effect in patients using fixed combinations of inhaled corticosteroids …

Observational studies indicate that overutilization of inhaled corticosteroids (ICS) is common
in patients with chronic obstructive pulmonary disease (COPD). Overprescription and the …

Chronic obstructive pulmonary disease (COPD) is a severely disabling chronic lung disease
characterized by persistent airway inflammation, which leads to limited expiratory airflow that …

Introduction: The frequent use of inhaled corticosteroids (ICSs), especially at higher doses,
has been accompanied by concern about both systemic and local side effects. Patients …

Inhaled oligonucleotide is an emerging therapeutic modality for various common respiratory
diseases, including obstructive airway diseases like asthma and chronic obstructive …

Long-acting bronchodilators in combination with inhaled corticosteroids (ICS) are
recommended to decrease the risk of recurrent exacerbations in patients with Global …

Ethnopharmacological relevance Chronic obstructive pulmonary disease (COPD) is a major
global health concern characterized by pulmonary inflammation and airway remodeling …

Introduction: Current guidelines recommend the use of inhaled long-acting bronchodilators,
inhaled corticosteroids (ICSs) and their combinations for maintenance treatment of moderate …